多賀峰克

タガミネカツ | TAGA Minekatsu

所属機関・部署：
職名：講師

研究分野 (1件)：泌尿器科学

研究キーワード (2件)：尿路悪性腫瘍 , malignancy of urinary tract

競争的資金等の研究課題 (2件)：

論文 (20件)：

Hasegawa T, Oyama N, Kasamatsu H, Chino T, Taga M, Hasegawa M. Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption. J Dermatol. 2022. 49. 12. e453-e454
Okumura Y, Kobayashi H, Tsutsumiuchi M, Seki M, Inamura S, Taga M, Fukushima M, Ito H, Yokoyama O, Terada N. Anticholinergic burden decreases voiding efficiency in the elderly facilities. ICS2022. 2022
Hisato Kbayashi, Xinmin Zha, Keiko Nagase, So Inamura, Minekatsu Taga, Yoshitaka Aoki, Hideaki Ito, Osamu Yokoyama. Phosphodiesterase 5 inhibitor suppresses prostate weight increase in type 2 diabetic rats. Life Sciences. 2022. 298. 120504
Saikawa Shiori, Taga Minekatsu, Matsuda Yasushi, Suzuki Koji, Yamaguchi Aina, Fukushima Mana, ImamuraYoshiaki, Ito Hideaki, Yokoyama Osamu. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney and its clinical features. IJU CASE REPORTS. 2022. 5. 5. 330-333
Hisato Kobayashi Katsuki Tsuchiyama, Minekatsu Taga, Takahiro Tokunaga, Hideaki Ito, Osamu Yokoyama. Impact of self-decision to stop cancer treatment on advanced genitourinary cancer patients. Medicine. 2021. 100. 14. 1-7

講演・口頭発表等 (16件)：

Works (3件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

多賀 峰克